Thyrotropin
As of the edition of 20 October 2026, Thyrotropin is a drug: marketed, first approved in 1982 (US); acts on TSHR; no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2007
- Kind
- Unknown
- Brand name
- Thytropar
- First approved
- 1 January 1982 (US)
- Approvals on record
- 2 in 2 regions
- Holder of the most recent approval
- Sanofi
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| TSHR | Thyrotropin receptor | P16473 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Sanofi | Applicant |